台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    96.1
  • 漲跌
    ▲0.9
  • 漲幅
    +0.95%
  • 成交量
    522
  • 產業
    上櫃 生技醫療類股
  • 306人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-元大-敦化 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

元大-敦化 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/01/13695.7300.0096.3061,3700.44%
2025/01/0800.001104.00103.00-11,299-0.08%
2025/01/03197.30197.1098.3001,2400.00%
2024/12/2600.00192.5092.50-11,225-0.08%
2024/12/1900.00087.3087.4001,2100.00%
2024/12/17186.5000.0086.7011,2230.08%
2024/11/28191.7000.0092.4011,1100.09%
2024/11/22594.7000.0093.8051,0310.48%
2024/11/21396.8000.0096.2031,0210.29%
2024/11/20196.4000.0096.5011,0180.10%
2024/11/19395.670.496.5096.002.61,0150.26%
2024/11/1800.000.296.5296.50-0.21,010-0.02%
2024/11/141102.5000.00101.5019710.10%
2024/11/1300.001106.50106.50-1946-0.11%
2024/11/110.1104.002104.00103.50-1.9882-0.22%
2024/11/067106.861102.50102.5068260.73%
2024/11/0500.002108.00106.00-2782-0.26%
2024/11/0411104.5010100.75100.0017580.13%
2024/11/018.5104.747107.29105.001.57300.21%
2024/10/292101.5000.00100.5026040.33%
2024/10/281101.0000.00102.0015760.17%
2024/10/2500.00298.5097.40-2513-0.39%
2024/10/2400.004.899.3098.30-4.8494-0.97%
2024/10/2300.00292.1593.70-2424-0.47%
2024/10/0800.00192.0091.10-1507-0.20%
2024/09/2000.00787.4387.40-7644-1.09%
2024/09/160.282.50182.7082.70-0.8641-0.13%
2024/09/1300.00482.3382.20-4644-0.62%
2024/09/09082.1000.0082.0006660.00%
2024/09/050.182.0000.0082.100.16890.01%
2024/08/201285.7100.0085.80127421.62%
2024/08/05187.2000.0083.0017640.13%
2024/07/30192.0000.0093.6017360.14%
2024/07/23193.9000.0094.5017200.14%
2024/07/1600.00197.0097.00-1658-0.15%
2024/07/08299.602100.25100.5006550.00%
2024/07/05297.30297.2097.5006250.00%
2024/07/0100.00299.50101.00-2610-0.33%
2024/06/2600.00197.4097.60-1576-0.17%
2024/06/12094.4000.0094.8006380.00%
2024/06/1100.00495.2395.40-4636-0.63%
2024/06/0700.00194.5094.50-1644-0.16%
2024/06/0500.00692.8792.90-6632-0.95%
2024/06/04191.6000.0090.8016470.15%
2024/05/3100.00191.0090.60-1729-0.14%
2024/05/30090.80590.3890.30-5737-0.68%
2024/05/28192.20192.3092.3007600.00%
2024/05/2200.00294.2594.10-2847-0.24%
2024/05/15194.90194.4093.9009520.00%
2024/04/2300.00189.8090.20-11,498-0.07%
2024/04/1200.004.197.3597.10-4.11,579-0.26%
2024/04/0300.00299.5099.00-21,777-0.11%
2024/03/21295.6000.0096.0021,8270.11%
2024/03/2000.001.194.5295.80-1.11,855-0.06%
2024/03/1900.00196.8096.80-11,864-0.05%
2024/03/1800.00193.3093.30-11,855-0.05%
2024/03/140.193.5000.0092.700.11,8820.01%
2024/03/080.296.9300.0095.100.21,9240.01%
2024/03/062.198.7000.0098.102.11,9370.11%
2024/03/050100.0000.00100.5001,9140.00%
2024/03/042101.5000.00100.5021,9240.10%
2024/02/2700.002104.00103.00-21,995-0.10%
2024/02/2600.000104.00104.5001,9900.00%
2024/02/233101.3300.00101.0031,9810.15%
2024/02/220.1101.5000.00101.000.12,0180.00%
2024/02/161102.5100.00102.0012,0960.05%
2024/02/153111.331110.50110.5022,0600.10%
2024/02/0500.002.1106.24106.50-2.12,024-0.10%
2024/02/0200.001105.50105.50-12,216-0.05%
2024/02/011107.007107.00107.00-62,281-0.26%
2024/01/3100.003106.17106.00-32,396-0.13%
智擎明、後年新藥將有斬獲 歐洲藥證+一期臨床數據結果Anue鉅亨-2023/11/03
智擎 相關文章